BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 556 filers reported holding BIO-TECHNE CORP in Q3 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $36,000 | 0.0% | 73 | -2.7% | 0.00% | 0.0% |
| Q3 2021 | $36,000 | +16.1% | 75 | +5.6% | 0.00% | 0.0% |
| Q2 2021 | $31,000 | +14.8% | 71 | -1.4% | 0.00% | 0.0% |
| Q1 2021 | $27,000 | +22.7% | 72 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $22,000 | +22.2% | 72 | -1.4% | 0.00% | 0.0% |
| Q3 2020 | $18,000 | -79.8% | 73 | -78.5% | 0.00% | -85.7% |
| Q2 2020 | $89,000 | +584.6% | 340 | +365.8% | 0.01% | +600.0% |
| Q1 2020 | $13,000 | -18.8% | 73 | -1.4% | 0.00% | 0.0% |
| Q4 2019 | $16,000 | 0.0% | 74 | -11.9% | 0.00% | 0.0% |
| Q3 2019 | $16,000 | -5.9% | 84 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $17,000 | +21.4% | 84 | +12.0% | 0.00% | 0.0% |
| Q1 2019 | $14,000 | +40.0% | 75 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $10,000 | -33.3% | 75 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $15,000 | +36.4% | 75 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $11,000 | 0.0% | 75 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $11,000 | +22.2% | 75 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $9,000 | 0.0% | 75 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $9,000 | -71.9% | 75 | -72.7% | 0.00% | -75.0% |
| Q2 2017 | $32,000 | +14.3% | 275 | -3.5% | 0.00% | 0.0% |
| Q1 2017 | $28,000 | -3.4% | 285 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $29,000 | -6.5% | 285 | 0.0% | 0.00% | -20.0% |
| Q3 2016 | $31,000 | -3.1% | 285 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $32,000 | +23.1% | 285 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $26,000 | +271.4% | 285 | +235.3% | 0.01% | +400.0% |
| Q4 2015 | $7,000 | -12.5% | 85 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $8,000 | +14.3% | 85 | +11.8% | 0.00% | 0.0% |
| Q2 2015 | $7,000 | – | 76 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadcrest Asset Management, LLC | 300,000 | $24,489,000 | 21.05% |
| Montanaro Asset Management Ltd | 388,800 | $31,737,744 | 5.02% |
| Sandhill Capital Partners LLC | 502,447 | $41,014,775 | 3.74% |
| Brown Capital Management | 3,160,892 | $258,023,614 | 3.66% |
| DF DENT & CO INC | 3,275,617 | $267,388,640 | 3.62% |
| Ownership Capital B.V. | 2,282,104 | $186,288,150 | 3.26% |
| Jackson Square Partners, LLC | 1,361,789 | $111,162,836 | 3.24% |
| STONE RUN CAPITAL, LLC | 88,135 | $7,194,460 | 3.20% |
| Pembroke Management, LTD | 339,591 | $27,720,813 | 2.99% |
| Summit Creek Advisors LLC | 283,693 | $23,157,860 | 2.90% |